88 related articles for article (PubMed ID: 12628308)
41. Augmentation of the activity of an immunotoxin, anti-Tac(Fv)-PE40KDEL, in T cell lines infected with human T cell leukemia virus type-I.
Ohno N; Kreitman RJ; Saito T; Masamoto I; Uozumi K; Hanada S; Takeuchi S; Furukawa T; Sumizawa T; Arima T; Akiyama S
Leuk Lymphoma; 2002 Apr; 43(4):885-8. PubMed ID: 12153180
[TBL] [Abstract][Full Text] [Related]
42. A bispecific immunotoxin (IHPP) with a long half-life targeting HER2 and PDGFRβ exhibited improved efficacy against HER2-positive tumors in a mouse xenograft model.
Guo R; Yang Y; Zhang D; Du J; Zhu X; Liu Y; Yang F; Lin J
Int J Pharm; 2021 Jan; 592():120037. PubMed ID: 33161038
[TBL] [Abstract][Full Text] [Related]
43. Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts.
Mossoba ME; Onda M; Taylor J; Massey PR; Treadwell S; Sharon E; Hassan R; Pastan I; Fowler DH
Clin Cancer Res; 2011 Jun; 17(11):3697-705. PubMed ID: 21521777
[TBL] [Abstract][Full Text] [Related]
44. Development of a Generic Anti-PEG Antibody Assay Using BioScale's Acoustic Membrane MicroParticle Technology.
Dong H; Mora JR; Brockus C; Chilewski SD; Dodge R; Merrifield C; Dickerson WM; DeSilva B
AAPS J; 2015 Nov; 17(6):1511-6. PubMed ID: 26139446
[TBL] [Abstract][Full Text] [Related]
45. Anti-mesothelin immunotoxin induces mesothelioma eradication, anti-tumor immunity, and the development of tertiary lymphoid structures.
Liu W; Tai CH; Liu X; Pastan I
Proc Natl Acad Sci U S A; 2022 Nov; 119(48):e2214928119. PubMed ID: 36409889
[TBL] [Abstract][Full Text] [Related]
46. A sandwich ELISA for the detection of Wnt5a.
Kummitha CM; Mayle KM; Christman MA; Deosarkar SP; Schwartz AL; McCall KD; Kohn LD; Malgor R; Goetz DJ
J Immunol Methods; 2010 Jan; 352(1-2):38-44. PubMed ID: 19919840
[TBL] [Abstract][Full Text] [Related]
47. Detection of thioredoxin in human serum and biological samples using a sensitive sandwich ELISA with digoxigenin-labeled antibody.
Das KC; White CW
J Immunol Methods; 1998 Feb; 211(1-2):9-20. PubMed ID: 9617827
[TBL] [Abstract][Full Text] [Related]
48. False positivity in a cyto-ELISA for anti-endothelial cell antibodies caused by heterophile antibodies to bovine serum proteins.
Revelen R; Bordron A; Dueymes M; Youinou P; Arvieux J
Clin Chem; 2000 Feb; 46(2):273-8. PubMed ID: 10657385
[TBL] [Abstract][Full Text] [Related]
49. A competitive ELISA for albumin in rat urine.
Chen X; Chen Y; Shen Z
J Immunoassay Immunochem; 2004; 25(1):81-9. PubMed ID: 15038619
[TBL] [Abstract][Full Text] [Related]
50. Mechanisms involved in serum-dependent inactivation of the immunotoxin enhancers monensin and carrier-protein-monensin.
Franceschi A; Dosio F; Anselmi C; Chignola R; Candiani C; Pasti M; Tridente G; Colombatti M
Eur J Biochem; 1994 Jan; 219(1-2):469-79. PubMed ID: 8307014
[TBL] [Abstract][Full Text] [Related]
51. ELISA for the detection of the lymphokine soluble immune response suppressor.
Aune TM
J Immunol Methods; 1985 Nov; 84(1-2):33-44. PubMed ID: 2415638
[TBL] [Abstract][Full Text] [Related]
52. Detection of ricin by colorimetric and chemiluminescence ELISA.
Poli MA; Rivera VR; Hewetson JF; Merrill GA
Toxicon; 1994 Nov; 32(11):1371-7. PubMed ID: 7886695
[TBL] [Abstract][Full Text] [Related]
53. Antibody-nanoparticle conjugates to enhance the sensitivity of ELISA-based detection methods.
Billingsley MM; Riley RS; Day ES
PLoS One; 2017; 12(5):e0177592. PubMed ID: 28494030
[TBL] [Abstract][Full Text] [Related]
54. Expression and Evaluation of HuscFv Antibody -PE40 Immunotoxin for Target Therapy of EGFR-Overexpressing Cancers.
Falahatgar D; Farajnia S; Zarghami N; Tanomand A; Khosroshahi SA; Akbari B; Farajnia H
Iran J Biotechnol; 2018 Dec; 16(4):e1743. PubMed ID: 31457033
[TBL] [Abstract][Full Text] [Related]
55. Validation of an ELISA for determination of antibodies induced in monkeys against Epi-hNE4, a recombinant protein inhibitor of human neutrophil elastase.
Dubois M; Delaunay V; Delestre L; Ezan E
J Pharm Biomed Anal; 2007 Mar; 43(4):1423-9. PubMed ID: 17118611
[TBL] [Abstract][Full Text] [Related]
56. Serological Profiling for Malaria Surveillance Using a Standard ELISA Protocol.
Murungi LM; Kimathi RK; Tuju J; Kamuyu G; Osier FHA
Methods Mol Biol; 2019; 2013():83-90. PubMed ID: 31267495
[TBL] [Abstract][Full Text] [Related]
57. Development and validation of an enzyme-linked immunosorbent assay to measure adalimumab concentration.
Desvignes C; Edupuganti SR; Darrouzain F; Duveau AC; Loercher A; Paintaud G; Mulleman D
Bioanalysis; 2015; 7(10):1253-60. PubMed ID: 26045004
[TBL] [Abstract][Full Text] [Related]
58. Development of an ELISA for the Pharmacokinetic Evaluation of a Murine Anti CD66 Monoclonal Antibody in Human Serum.
Langford J; Chowdhury F; Orchard K
J Immunoassay Immunochem; 2015; 36(6):579-96. PubMed ID: 25715051
[TBL] [Abstract][Full Text] [Related]
59. Generic Anti-PEG Antibody Assay on ProterixBio's (Formerly BioScale) ViBE Platform Shows Poor Reproducibility.
Chilewski SD; Shields J; Mora JR; Myler H
AAPS J; 2018 Apr; 20(3):65. PubMed ID: 29691672
[TBL] [Abstract][Full Text] [Related]
60. Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers.
Skorupan N; Peer CJ; Zhang X; Choo-Wosoba H; Ahmad MI; Lee MJ; Rastogi S; Sato N; Yu Y; Pegna GJ; Steinberg SM; Kalsi SS; Cao L; Figg WD; Trepel JB; Pastan I; FitzGerald D; Alewine C
Front Oncol; 2024; 14():1386190. PubMed ID: 38706610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
